Gene Editing of the Major Cat Allergen, Fel d 1

Indoor Biotechnologies is applying CRISPR gene editing to delete Fel d 1 from cat cells, an approach to creating a hypoallergenic cat. Join Indoor Biotechnologies scientists to discuss details of the CRISPR Cat project on the holiday edition of our webinar series on Wednesday, December 8^th at 11am EST.

Indoor Biotechnologies scientists are investigating the role of Fel d 1 across all cats, both domesticated and wild. Fel d 1 is the cat allergen of choice as it accounts for 60-90% of anti-cat IgE. Significant research has been conducted at Indoor Biotechnologies to identify conserved regions of the Fel d 1 genes and to delete Fel d 1 from feline cells using CRISPR as an approach that could ultimately be used to generate Fel d 1-free cats.
The webinar will cover CRISPR Cat in detail, providing the origins, technical background, data, and future goals of the project.

Learning Objectives:

• Learn more on the history of CRISPR Cat, including how the gene for Fel d 1 was first isolated.
• Learn more about CRISPR Cat milestones to date, including the development, methods, and results.
• Understand the importance of CRISPR Cat, and how the project may have larger implications on the application of CRISPR technology in allergy.